argenx SE reported 35.53 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
AstraZeneca 25.34 4.25 Jun/2026
Genmab 17.14 4.39 Dec/2025
GlaxoSmithKline 10.63 4.24 Jun/2026
GRIFOLS 14.71 3.73 Jun/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Lakefront Biotherapeutics 2.54 0.6 Mar/2026
Qiagen NV 19.48 1.06 Mar/2026
UCB 29.7 5.52 Dec/2025